Skip to content
10-Q

Quarterly Report

OCTAVE SPECIALTY GROUP INC OSG

0001628280-26-031393

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 45.01M sh
Long Term Debt Q1 2026 · Apr 1, 2026 $139.38M
Long Term Debt Q1 2026 · Mar 31, 2026 $117.06M
Long Term Debt Q1 2026 · Dec 31, 2025 $117.56M
Long Term Debt Q1 2026 · Oct 31, 2025 $100M
Shares Diluted Q1 2026 · Mar 31, 2026 45.3M sh
Shares Diluted Q1 2026 · Mar 31, 2025 47.31M sh
Short Term Debt Q1 2026 · Mar 31, 2026 $0
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Stockholders Equity Q1 2026 · Mar 31, 2026 $712.62M
Stockholders Equity Q1 2026 · Dec 31, 2025 $715.79M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.24B
Total Liabilities Q1 2026 · Dec 31, 2025 $1.14B
Total Assets Q1 2026 · Mar 31, 2026 $2.27B
Total Assets Q1 2026 · Dec 31, 2025 $2.22B
Total Assets Q1 2026 · Mar 31, 2025 $8.25B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.13
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$1.21
Eps Basic Q1 2026 · Mar 31, 2026 −$0.13
Eps Basic restated Q1 2026 · Mar 31, 2025 −$1.21
Sga Expense Q1 2026 · Mar 31, 2026 $53.16M
Sga Expense Q1 2026 · Mar 31, 2025 $38.53M
Net Income Q1 2026 · Mar 31, 2026 −$6.85M
Net Income restated Q1 2026 · Mar 31, 2025 −$46.39M
Revenue Q1 2026 · Mar 31, 2026 $68.18M
Revenue Q1 2026 · Mar 31, 2025 $36.77M